Rareview Total Return Bond ETF (RTRE)
Live price chart, market sentiment, and community perspectives for Rareview Total Return Bond ETF (CBOE: RTRE).
Live price chart, market sentiment, and community perspectives for Rareview Total Return Bond ETF (CBOE: RTRE).
On our desk, evaluating the Rareview Total Return Bond ETF (RTRE) comes down to efficiency versus active overhead. With an expense ratio hovering around 1.33% and trailing 1-year NAV returns of 2.8%—lagging the Intermediate Core-Plus Bond category average of 3.2%—market sentiment remains cautious. The fund's active strategy, which includes a portfolio turnover rate of 132% and allocations into affiliated products like the Rareview Dynamic Fixed Income ETF, means we are paying a premium for a structure that has recently underperformed its category peers, receiving D and F grades from Morningstar for recent monthly and yearly intervals.
Watching the fixed income landscape in 2026, the macro environment is fraught with sticky inflation, potential stagflation risks, and shifting monetary policies. Against this volatile backdrop, RTRE holds 176 positions, including heavy weightings in U.S. Treasury Notes and tactical allocations to emerging market debt. However, fixed income risks remain pronounced: rising interest rates drive down debt security values, and active management introduces distinct structural risks. Without principal protection and given the broader market's underestimation of long-term inflation threats, we are keeping a very tight risk profile on actively managed core-plus vehicles.
When analyzing RTRE for fixed income allocation models, our quantitative team stresses the operational mechanics. The fund features an inception date of May 31, 2024, managed by Rareview Capital LLC, with total net assets around $59.9 million and an average daily volume of roughly 9.74K shares. Technical analysts must account for the active management overlay, tracking error against the Bloomberg U.S. Aggregate Bond Index benchmark, and the impact of fee waivers expiring. When reviewing execution protocols, the spread between NAV and price returns—alongside tactical shifts into derivative or options structures utilized in related strategies—requires careful quantitative backtesting.
Explore plasma cleansing, somatic organ swaps, and BCI.